People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Grid Therapeutics LLC | — | Biotechnology | Series A | $8.2M | $19.9M | 2018 |
Richard F. Parker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard F. Parker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Parker | 1 | 4 |
| Kevin Schulman | 1 | 2 |
| Thomas F. Patz | 1 | 1 |
| Edward F. Patz, Jr. | 1 | 1 |
| Scott F. Lyman | 1 | 1 |
| Paolo F. Paoletti | 1 | 1 |
| Edward Patz, Jr. | 1 | 1 |
| Paolo Paoletti | 1 | 1 |
| Thomas Patz | 1 | 1 |
| Scott Lyman | 1 | 1 |
| Thomas L. Patz | 1 | 1 |
| Kevin F. Schulman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.